Few & Far Between: How Biotech Gets Built
By Chris O'Brien
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Chris O'Brien
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 35
Description
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
| Episode | Date |
|---|---|
|
Episode 71: Chris O'Brien, Former Biorasi CEO and Current CEO of Rancho Biosciences
|
May 12, 2026 |
|
Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School
|
Mar 17, 2026 |
|
Video Episode 68: Sinan Gölhan, CEO at GelTech Labs
|
Jan 27, 2026 |
|
Video Episode 67: Aoife Brennan, President and CEO of Climb Bio
|
Jan 07, 2026 |
|
Episode 66: Mark Abelson, Founder of Ora Clinical
|
Dec 16, 2025 |
|
Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
|
Nov 24, 2025 |
|
Video Episode 64 - Professor Justin Stebbing
|
Nov 11, 2025 |
|
Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences
|
Oct 28, 2025 |
|
Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology
|
Oct 22, 2025 |
|
Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics
|
Oct 01, 2025 |
|
Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech
|
Sep 17, 2025 |
|
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
|
Sep 03, 2025 |
|
Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences
|
Aug 14, 2025 |
|
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
|
Jul 22, 2025 |
|
Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
|
Jul 15, 2025 |
|
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
|
Jul 09, 2025 |
|
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
|
May 28, 2025 |
|
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
|
Apr 29, 2025 |
|
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
|
Apr 23, 2025 |
|
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
|
Apr 03, 2025 |
|
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
|
Mar 18, 2025 |
|
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
|
Feb 27, 2025 |
|
Episode 48: John Celebi, President and CEO, Sensei Bio
|
Feb 18, 2025 |
|
Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures
|
Jan 15, 2025 |
|
Episode 47 - Marc Lajoie, CEO at Outpace Bio
|
Dec 31, 2024 |
|
Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
|
Dec 12, 2024 |
|
Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
|
Oct 23, 2024 |
|
Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics
|
Sep 12, 2024 |
|
Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical
|
Jul 16, 2024 |
|
Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health
|
May 23, 2024 |
|
Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal
|
Apr 25, 2024 |
|
Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center
|
Mar 26, 2024 |
|
Episode 38: Dr. Ole Isacson, Professor of Neurology and Neuroscience, Harvard Medical School
|
Feb 22, 2024 |
|
Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche
|
Jan 24, 2024 |
|
Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School
|
Dec 05, 2023 |